 | • レポートコード：D005-03911 • 出版社/出版日：GlobalInfoResearch / 2020年5月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、コレラワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。コレラワクチンの種類別市場規模（Dukoral、Shanchol、Vaxchora、その他）、用途別市場規模（病院、科学研究、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Valneva、Celldex Therapeutics、PaxVax、Shantha Biotechnics Limited、Ceva Asia、Merck ・地域別グローバル市場分析 2015年-2020年 ・コレラワクチンの北米市場（アメリカ、カナダ、メキシコ） ・コレラワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・コレラワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・コレラワクチンの南米市場（ブラジル、アルゼンチン） ・コレラワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：Dukoral、Shanchol、Vaxchora、その他 ・用途別分析：病院、科学研究、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Cholera Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.5% in the forecast period of 2020 to 2025 and will expected to reach USD 95 million by 2025, from USD 68 million in 2019.
The Cholera Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Cholera Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Cholera Vaccine market has been segmented into
Dukoral
Shanchol
Vaxchora
Others
By Application, Cholera Vaccine has been segmented into:
Hospital
Scientific Research
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cholera Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Cholera Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cholera Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the Cholera Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Cholera Vaccine Market Share Analysis
Cholera Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cholera Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cholera Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in Cholera Vaccine are:
Valneva
Celldex Therapeutics
PaxVax
Shantha Biotechnics Limited
Ceva Asia
Merck
Among other players domestic and global, Cholera Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cholera Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cholera Vaccine, with price, sales, revenue and global market share of Cholera Vaccine in 2018 and 2019.
Chapter 3, the Cholera Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cholera Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Cholera Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Cholera Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Cholera Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cholera Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Dukoral
1.2.3 Shanchol
1.2.4 Vaxchora
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Cholera Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Scientific Research
1.3.4 Others
1.4 Overview of Global Cholera Vaccine Market
1.4.1 Global Cholera Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Valneva
2.1.1 Valneva Details
2.1.2 Valneva Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Valneva SWOT Analysis
2.1.4 Valneva Product and Services
2.1.5 Valneva Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Celldex Therapeutics
2.2.1 Celldex Therapeutics Details
2.2.2 Celldex Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Celldex Therapeutics SWOT Analysis
2.2.4 Celldex Therapeutics Product and Services
2.2.5 Celldex Therapeutics Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 PaxVax
2.3.1 PaxVax Details
2.3.2 PaxVax Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 PaxVax SWOT Analysis
2.3.4 PaxVax Product and Services
2.3.5 PaxVax Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Shantha Biotechnics Limited
2.4.1 Shantha Biotechnics Limited Details
2.4.2 Shantha Biotechnics Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Shantha Biotechnics Limited SWOT Analysis
2.4.4 Shantha Biotechnics Limited Product and Services
2.4.5 Shantha Biotechnics Limited Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Ceva Asia
2.5.1 Ceva Asia Details
2.5.2 Ceva Asia Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Ceva Asia SWOT Analysis
2.5.4 Ceva Asia Product and Services
2.5.5 Ceva Asia Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck SWOT Analysis
2.6.4 Merck Product and Services
2.6.5 Merck Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Cholera Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Cholera Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Cholera Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Cholera Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Cholera Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Cholera Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Cholera Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Cholera Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Cholera Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Cholera Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Cholera Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Cholera Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Cholera Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Cholera Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Cholera Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Cholera Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Cholera Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Cholera Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Cholera Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Cholera Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Cholera Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Cholera Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Cholera Vaccine Sales and Growth Rate (2015-2020)
6.4 France Cholera Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Cholera Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Cholera Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Cholera Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Cholera Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Cholera Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Cholera Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Cholera Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Cholera Vaccine Sales and Growth Rate (2015-2020)
7.5 India Cholera Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Cholera Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Cholera Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Cholera Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Cholera Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Cholera Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Cholera Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Cholera Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Cholera Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Cholera Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Cholera Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Cholera Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Cholera Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Cholera Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Cholera Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Cholera Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Cholera Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Cholera Vaccine Price by Type (2015-2020)
11 Global Cholera Vaccine Market Segment by Application
11.1 Global Cholera Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Cholera Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Cholera Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Cholera Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Cholera Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Cholera Vaccine Market Forecast (2021-2025)
12.2.2 Europe Cholera Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Cholera Vaccine Market Forecast (2021-2025)
12.2.4 South America Cholera Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Cholera Vaccine Market Forecast (2021-2025)
12.3 Cholera Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Cholera Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Cholera Vaccine Market Share Forecast by Type (2021-2025)
12.4 Cholera Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Cholera Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Cholera Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Cholera Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cholera Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cholera Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Valneva Basic Information, Manufacturing Base and Competitors
Table 8. Valneva Cholera Vaccine Major Business
Table 9. Valneva Cholera Vaccine Total Revenue (USD Million) (2018-2019)
Table 10. Valneva SWOT Analysis
Table 11. Valneva Cholera Vaccine Product and Services
Table 12. Valneva Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Celldex Therapeutics Basic Information, Manufacturing Base and Competitors
Table 14. Celldex Therapeutics Cholera Vaccine Major Business
Table 15. Celldex Therapeutics Cholera Vaccine Total Revenue (USD Million) (2018-2019)
Table 16. Celldex Therapeutics SWOT Analysis
Table 17. Celldex Therapeutics Cholera Vaccine Product and Services
Table 18. Celldex Therapeutics Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. PaxVax Basic Information, Manufacturing Base and Competitors
Table 20. PaxVax Cholera Vaccine Major Business
Table 21. PaxVax Cholera Vaccine Total Revenue (USD Million) (2018-2019)
Table 22. PaxVax SWOT Analysis
Table 23. PaxVax Cholera Vaccine Product and Services
Table 24. PaxVax Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Shantha Biotechnics Limited Basic Information, Manufacturing Base and Competitors
Table 26. Shantha Biotechnics Limited Cholera Vaccine Major Business
Table 27. Shantha Biotechnics Limited Cholera Vaccine Total Revenue (USD Million) (2018-2019)
Table 28. Shantha Biotechnics Limited SWOT Analysis
Table 29. Shantha Biotechnics Limited Cholera Vaccine Product and Services
Table 30. Shantha Biotechnics Limited Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Ceva Asia Basic Information, Manufacturing Base and Competitors
Table 32. Ceva Asia Cholera Vaccine Major Business
Table 33. Ceva Asia Cholera Vaccine Total Revenue (USD Million) (2018-2019)
Table 34. Ceva Asia SWOT Analysis
Table 35. Ceva Asia Cholera Vaccine Product and Services
Table 36. Ceva Asia Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Merck Basic Information, Manufacturing Base and Competitors
Table 38. Merck Cholera Vaccine Major Business
Table 39. Merck Cholera Vaccine Total Revenue (USD Million) (2018-2019)
Table 40. Merck SWOT Analysis
Table 41. Merck Cholera Vaccine Product and Services
Table 42. Merck Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Global Cholera Vaccine Sales by Manufacturer (2018-2019) (K Units)
Table 44. Global Cholera Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 45. Global Cholera Vaccine Sales by Regions (2015-2020) (K Units)
Table 46. Global Cholera Vaccine Sales Market Share by Regions (2015-2020)
Table 47. Global Cholera Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 48. North America Cholera Vaccine Sales by Countries (2015-2020) (K Units)
Table 49. North America Cholera Vaccine Sales Market Share by Countries (2015-2020)
Table 50. North America Cholera Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 51. North America Cholera Vaccine Revenue Market Share by Countries (2015-2020)
Table 52. Europe Cholera Vaccine Sales by Countries (2015-2020) (K Units)
Table 53. Europe Cholera Vaccine Sales Market Share by Countries (2015-2020)
Table 54. Europe Cholera Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 55. Asia-Pacific Cholera Vaccine Sales by Regions (2015-2020) (K Units)
Table 56. Asia-Pacific Cholera Vaccine Sales Market Share by Regions (2015-2020)
Table 57. Asia-Pacific Cholera Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 58. South America Cholera Vaccine Sales by Countries (2015-2020) (K Units)
Table 59. South America Cholera Vaccine Sales Market Share by Countries (2015-2020)
Table 60. South America Cholera Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 61. South America Cholera Vaccine Revenue Market Share by Countries (2015-2020)
Table 62. Middle East & Africa Cholera Vaccine Sales by Countries (2015-2020) (K Units)
Table 63. Middle East & Africa Cholera Vaccine Sales Market Share by Countries (2015-2020)
Table 64. Middle East & Africa Cholera Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 65. Middle East & Africa Cholera Vaccine Revenue Market Share by Countries (2015-2020)
Table 66. Global Cholera Vaccine Sales by Type (2015-2020) (K Units)
Table 67. Global Cholera Vaccine Sales Share by Type (2015-2020)
Table 68. Global Cholera Vaccine Revenue by Type (2015-2020) (USD Million)
Table 69. Global Cholera Vaccine Revenue Share by Type (2015-2020)
Table 70. Global Cholera Vaccine Sales by Application (2015-2020) (K Units)
Table 71. Global Cholera Vaccine Sales Share by Application (2015-2020)
Table 72. Global Cholera Vaccine Sales Forecast by Regions (2021-2025) (K Units)
Table 73. Global Cholera Vaccine Market Share Forecast by Regions (2021-2025)
Table 74. Global Cholera Vaccine Sales Forecast by Type (2021-2025) (K Units)
Table 75. Global Cholera Vaccine Market Share Forecast by Type (2021-2025)
Table 76. Global Cholera Vaccine Sales Forecast by Application (2021-2025)
Table 77. Global Cholera Vaccine Market Share Forecast by Application (2021-2025)
Table 78. Direct Channel Pros & Cons
Table 79. Indirect Channel Pros & Cons
Table 80. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Cholera Vaccine Picture
Figure 2. Global Sales Market Share of Cholera Vaccine by Type in 2019
Figure 3. Dukoral Picture
Figure 4. Shanchol Picture
Figure 5. Vaxchora Picture
Figure 6. Others Picture
Figure 7. Cholera Vaccine Sales Market Share by Application in 2018
Figure 8. Hospital Picture
Figure 9. Scientific Research Picture
Figure 10. Others Picture
Figure 11. Global Cholera Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Cholera Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Cholera Vaccine Sales Market Share by Manufacturer in 2019
Figure 32. Global Cholera Vaccine Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Cholera Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Cholera Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Cholera Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Cholera Vaccine Revenue Market Share by Regions (2015-2020)
Figure 39. Global Cholera Vaccine Revenue Market Share by Regions in 2018
Figure 40. North America Cholera Vaccine Sales and Growth Rate (2015-2020)
Figure 41. Europe Cholera Vaccine Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Cholera Vaccine Sales and Growth Rate (2015-2020)
Figure 43. South America Cholera Vaccine Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Cholera Vaccine Sales and Growth Rate (2015-2020)
Figure 45. North America Cholera Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Cholera Vaccine Sales Market Share by Countries (2015-2020)
Figure 47. North America Cholera Vaccine Sales Market Share by Countries in 2018
Figure 48. North America Cholera Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Cholera Vaccine Revenue Market Share by Countries in 2018
Figure 50. United States Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Cholera Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Cholera Vaccine Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Cholera Vaccine Revenue Market Share by Countries in 2019
Figure 56. Germany Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Cholera Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Cholera Vaccine Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Cholera Vaccine Revenue Market Share by Regions 2019
Figure 64. China Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Cholera Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Cholera Vaccine Sales Market Share by Countries in 2019
Figure 71. South America Cholera Vaccine Revenue Market Share by Countries in 2019
Figure 72. Brazil Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Cholera Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Cholera Vaccine Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Cholera Vaccine Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Cholera Vaccine Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Cholera Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Cholera Vaccine Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Cholera Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Cholera Vaccine Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Cholera Vaccine Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Cholera Vaccine Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Cholera Vaccine Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Cholera Vaccine Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
イヌインフルエンザワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Canine Influenza Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Canine Influenza Vac…- 水痘ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Chickenpox Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Chickenpox Vaccine market …
- 樹状細胞がんワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Dendritic Cell Cancer Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Dendritic Cell …
- クラスII生物学的安全キャビネットの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Class II Biological Safety Cabinet market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Class II B…
- バルーン拡張器の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Balloon Dilator market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Balloon Dilator market report…